cancer cells. Cancer Cell,
7(6), 561-573 (2005).
4. Hay, R.J. et al., eds., ATCC Quality Control
Methods for Cell Lines. 2nd edition, Published by
ATCC (1992).
5. Caputo, J.L., Biosafety procedures
by resting and IL-15-activated
human natural killer cells. Cancer Immunol Immunother 2015 May; 64(5):573-583. Epub
2015 Feb 18.
165. Cho H et al. MICA/B and ULBP1 NKG2D ligands are independent predictors
L9393 284217 LAMA1 P NP_005550.2 y n/d n/d
418 MAGI-1 M5691 308113 Cnksr3 P NP_001012061.1 n/d n/d y
573 PINCH-1 P9371 309798 Gcc2 M NP_001101103.1 y y y
444 Mcl-1 M8434 338339 CLEC4D P NP_525126.2 y n/d
L9393 284217 LAMA1 P NP_005550.2 y n/d n/d
418 MAGI-1 M5691 308113 Cnksr3 P NP_001012061.1 n/d n/d y
573 PINCH-1 P9371 309798 Gcc2 M NP_001101103.1 y y y
444 Mcl-1 M8434 338339 CLEC4D P NP_525126.2 y n/d
L9393 284217 LAMA1 P NP_005550.2 y n/d n/d
418 MAGI-1 M5691 308113 Cnksr3 P NP_001012061.1 n/d n/d y
573 PINCH-1 P9371 309798 Gcc2 M NP_001101103.1 y y y
444 Mcl-1 M8434 338339 CLEC4D P NP_525126.2 y n/d
(PSR) P1495 P y y n/d
570 Negative Control NA
571 PIAS-x P9498 M y n/d n/d
572 Negative Control NA
573 PINCH-1 P9371 M y y y
574 Protein Kinase Bα /Akt1 P2482 M y y y
575 Protein Kinase Bα /Akt1 P1601 P